As of 2025-07-06, the Intrinsic Value of Anterix Inc (ATEX) is 29.09 USD. This Anterix valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 25.23 USD, the upside of Anterix Inc is 15.30%.
The range of the Intrinsic Value is 8.68 - 53.60 USD
Based on its market price of 25.23 USD and our intrinsic valuation, Anterix Inc (ATEX) is undervalued by 15.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (2,540.43) - (227.19) | (408.53) | -1719.2% |
| DCF (Growth 10y) | (370.71) - (3,955.56) | (652.24) | -2685.2% |
| DCF (EBITDA 5y) | 8.68 - 53.60 | 29.09 | 15.3% |
| DCF (EBITDA 10y) | 26.94 - 162.85 | 87.71 | 247.6% |
| Fair Value | -7.64 - -7.64 | -7.64 | -130.28% |
| P/E | (13.60) - (8.86) | (10.61) | -142.1% |
| EV/EBITDA | (19.85) - 25.85 | (4.63) | -118.4% |
| EPV | (57.38) - (66.00) | (61.69) | -344.5% |
| DDM - Stable | (9.45) - (73.54) | (41.49) | -264.5% |
| DDM - Multi | (22.42) - (136.63) | (38.62) | -253.1% |
| Market Cap (mil) | 469.03 |
| Beta | 0.50 |
| Outstanding shares (mil) | 18.59 |
| Enterprise Value (mil) | 421.65 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.61% |
| Cost of Debt | 5.00% |
| WACC | 5.57% |